VEGFA and POEMS syndrome: Immunomodulatory agents such as thalidomide and lenalidomide are candidates to be treatment options for POEMS syndrome because they excellently suppressed the proliferation of monoclonal plasma cell as well as anti-VEGF and anti-cytokines (21, 58–60).